Trial Profile
Efficacy of sofosbuvir based therapy in Egyptian patients with hepatitis C and advanced fibrosis/cirrhosis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Feb 2020
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms HERACLES B
- 23 May 2016 New trial record
- 17 Apr 2016 Results (n=5243) presented at The International Liver Congress™ 2016